Shield Therapeutics plc
Healthcare · EUR · F
Price
€0.064
Cap
€73.29M
Earnings
—
30d Trend
-35.4%
BRAIN47 SIGNAL
Raw weighted: 47×Macro 0.99 (−1%)=47
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
6-9 month momentum thesis — strong trend with confirmation
BRAIN47'S ASSESSMENT
I rate Shield Therapeutics plc at 47/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is momentum at 84/100. I classify this as a speculative position with the strongest thesis on a medium-term horizon.
DETAILED ANALYSIS
6-9 month momentum thesis — strong trend with confirmation. Momentum (84) and Quality (53) are the primary strengths. I note that fundamentals is the weakest area at 20/100 — this warrants monitoring. I classify this as a speculative position — elevated volatility at 71% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.